Handwriting as an objective tool for Parkinson’s disease diagnosis

被引:0
作者
Sara Rosenblum
Margalit Samuel
Sharon Zlotnik
Ilana Erikh
Ilana Schlesinger
机构
[1] University of Haifa,Department of Occupational Therapy, Faculty of Social Welfare and Health Sciences
[2] Rambam Health Care Campus,Department of Occupational Therapy
[3] Rambam Health Care Campus,Department of Neurology, Technion Faculty of Medicine
来源
Journal of Neurology | 2013年 / 260卷
关键词
Parkinson’s disease; Biomarker; Non-motor; Handwriting; Diagnosis; Digitizer;
D O I
暂无
中图分类号
学科分类号
摘要
To date, clinical assessment remains the gold standard in the diagnosis of Parkinson’s disease (PD). We sought to identify simple characteristics of handwriting which could accurately differentiate PD patients from healthy controls. Twenty PD patients and 20 matched controls wrote their name and copied an address on a paper affixed to a digitizer. Mean pressure and mean velocity was measured for the entire task and the spatial and temporal characteristics were measured for each stroke. Results of the MANOVAs for the temporal, spatial, and pressure measures (stroke length, width, and height; mean pressure; mean time per stroke; mean velocity), for both the name writing and address copying tasks, showed significant group effects (F(6,32) = 6.72, p < 0.001; F(6,31) = 14.77, p < 0.001, respectively). A discriminant analysis was performed for the two tasks. One discriminant function was found for the group classification of all participants (Wilks’ Lambda = 0.305, p < 0.001). Based on this function, 97.5 % of participants were correctly classified (100 % of the controls and 95 % of PD patients). A Kappa value of 0.947 (p < 0.001) was calculated, demonstrating that the group classification did not occur by chance. In this pilot study we identified two simple short and routine writing tasks which differentiate PD patients from healthy controls. These writing tasks have future potential as cost-effective, fast and reliable biomarkers for PD.
引用
收藏
页码:2357 / 2361
页数:4
相关论文
共 110 条
  • [1] Marek K(2011)The Parkinson progression marker Initiative (PPMI) Prog Neurobiol 95 629-663
  • [2] Jennings D(2009)A longitudinal program for biomarker development in Parkinson’s disease: a feasibility study Mov Disord 24 2081-2090
  • [3] Lasch S(2013)Detection of Alzheimer’s and Parkinson’s disease from exhaled breath using nanomaterial-based sensors Nanomedicine (Lond) 8 43-56
  • [4] Ravina B(2011)Preclinical biomarkers of Parkinson disease Arch Neurol 68 22-30
  • [5] Tanner C(2011)Diagnostic markers for Parkinson’s disease Curr Opin Neurol 24 309-317
  • [6] Dieuliis D(2012)Role of DaTSCAN and clinical diagnosis in Parkinson disease Neurology 78 696-701
  • [7] Eberly S(2003)The aging hand J Gerontol A Biol Sci Med Sci 58 146-152
  • [8] Flagg E(1995)An essay on Wilhelm von Humboldt and the shaking palsy: first comprehensive description of Parkinson’s disease by a patient Neurology 45 565-568
  • [9] Galpern WR(1996)Computational analysis of open loop handwriting movements in Parkinson’s disease: a rapid method to detect dopamimetic effects Mov Disord 11 289-297
  • [10] Fahn S(1998)Handwriting and speech changes across the levodopa cycle in Parkinson’s disease Acta psycho (Amst) 100 71-84